Eptifibatide bridging therapy for staged carotid artery stenting and cardiac surgery: Safety and feasibility.

Michael Travis CatonKazim H NarsinhAmanda BakerMatthew R AmansSteven W HettsJoseph H RappJames C IanuzziElaine TsengWarren J GasperDaniel L Cooke

Published in: Vascular (2022)

For patients undergoing staged CAS-CTS, Eptifibatide bridging therapy is a viable temporary antiplatelet strategy with a favorable safety profile. This strategy enables a flexible range of time-intervals between procedures.

Keyphrases

cardiac surgery
patients undergoing
crispr cas
acute kidney injury
genome editing
antiplatelet therapy
coronary artery disease
acute coronary syndrome
cell therapy
smoking cessation